BRAINSTORM CELL THERAPEUTICS INC. Common Stock, Par or Stated Value Per Share
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Common Stock, Par or Stated Value Per Share of $0.00 per share as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockParOrStatedValuePerShare · last filed 2026-08-14
- 2026-06-30: Common Stock, Par or Stated Value Per Share $0.00.
- 2026-03-31: Common Stock, Par or Stated Value Per Share $0.00.
- 2025-12-31: Common Stock, Par or Stated Value Per Share $0.00.
- 2025-09-30: Common Stock, Par or Stated Value Per Share $0.00.
| Period end | Common Stock, Par or Stated Value Per Share | Common Stock, Par or Stated Value Per Share as first filed |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $0.00 10-K · filed 2024-04-01 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-04-26 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-28 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-10-15 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $0.00 10-K · filed 2021-02-04 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $0.00 10-K · filed 2020-02-18 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-07-23 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $0.00 10-K · filed 2019-04-01 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-10-17 | |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-08 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-29 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-09 | |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-11-13 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-26 | $0.00 10-K · filed 2014-03-27 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $0.00 10-K · filed 2014-03-27 | |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $0.00 10-Q/A · filed 2012-08-29 | |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $0.00 10-K · filed 2013-03-14 | |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $0.00 10-Q/A · filed 2011-09-07 | |
| 2010-12-31 | $0.00 10-K · filed 2012-03-15 | |
| 2004-05-21 | $0.00 10-Q · filed 2014-08-12 | $0.00 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |